Provision of an AKTA Pure 150M Machine

In order for Public Health England (PHE) to prepare antigens to support clinical trials and to fulfil both scientific and regulatory objectives, it is necessary they purchase an AKTA Pure 150M to replace an aging AKTA FPLC. This purchase will allow the team to produce antigens, toxins and other bacterial proteins of the required specification for production of immunotherapeutics and vaccines for use in clinical trials. The justifications behind purchasing the AKTA Pure 150M are: - The unicorn software is required i...